Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT01846624 · TERMINATED

Trial details

NCT number: NCT01846624
Sponsor: David Iberri
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults AML (Adult) With 11q23 (MLL) Abnormalities AML (Adult) With Del (5q)AML (Adult) With Inv (16) (p13; q22)AML (Adult) With t (16;16) (p13; q22)AML (Adult) With t (8; 21) (q22; q22)Secondary AML (Adult)Untreated AML (Adult)

Start date: 2013-06-01
Primary completion: 2016-07-22
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.